Concepedia

Paul Kussie

PK

Statistics

Publications

42

Citations

4.3K

H-Index

31

Active since

1988

Affiliations

SciClone Pharmaceuticals (United States)(Current)

Columbia University

Massachusetts General Hospital

Paul Kussie is an author at SciClone Pharmaceuticals (United States) specializing in life sciences, pharmacology, and molecular biology.

Publications per year

1988–2016

42

Publications

42

Structural basis for inhibition of the epidermal growth factor receptor by cetuximab

Shiqing Li, Karl R. Schmitz, Philip D. Jeffrey et al. · Cancer Cell · 2005 · 1.1K citations · Full text

, , +13

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Douglas Burtrum, Zhenping Zhu, Dan Lu et al. · PubMed · 2003 · 349 citations

, , +15

Conservation of Structure and Mechanism between Eukaryotic Topoisomerase I and Site-Specific Recombinases

Chonghui Cheng, Paul Kussie, Nikola P. Pavletich et al. · Cell · 1998 · 234 citations · Full text

, , +10

Cloning and Functional Expression of a Human Heparanase Gene

Paul Kussie, Jeffrey D. Hulmes, Dale L. Ludwig et al. · Biochemical and Biophysical Research Communications · 1999 · 200 citations

, , +6

High heparanase activity in multiple myeloma is associated with elevated microvessel density.

Thomas J. Kelly, Hua‐Quan Miao, Yang Yang et al. · PubMed · 2003 · 167 citations

, , +17

1–5 of 42